Skip to main content

Michael John Kelley

Professor of Medicine
Medicine, Medical Oncology
Duke Box 3396, Durham, NC 27710
508 Fulton St; Hem-Onc 111G, Durham, NC 27705

Selected Grants


Postdoctoral Training in Genomic Medicine Research

Inst. Training Prgm or CMECo-Mentor · Awarded by National Institutes of Health · 2017 - 2023

Exploiting targeted therapy-induced ATM dependence in residual lung tumors

ResearchCollaborator · Awarded by Department of Defense · 2021 - 2023

Preference Tx for Sequencing in NSCLC

ResearchCo Investigator · Awarded by AstraZeneca Pharmaceuticals, LP · 2018 - 2021

Stage III NSCLC in the VA Health System

ResearchCo Investigator · Awarded by AstraZeneca Pharmaceuticals, LP · 2018 - 2020

EGFR Testing Patterns and Outcomes in Non-Small Cell Lung Cancer in the VA Health System

ResearchCo Investigator · Awarded by AstraZeneca Pharmaceuticals, LP · 2018 - 2020

IPA - Bradley Hintze

ResearchPrincipal Investigator · Awarded by Durham Veterans Affairs Medical Center · 2017 - 2019

Chordoma Foundation Brachyury Mouse Model Project

ResearchPrincipal Investigator · Awarded by Chordoma Foundation · 2016 - 2018

Chordoma Genetically Engineered Mouse Model

ResearchPrincipal Investigator · Awarded by Chordoma Foundation · 2014 - 2015

IPA - David Alcorta

ResearchPrincipal Investigator · Awarded by Veterans Administration Medical Center · 2013 - 2013

Young Smokers' Reactions to Genetic Risk for Lung Cancer

ResearchCo Investigator · Awarded by National Institutes of Health · 2007 - 2013

IPA - David Alcorta

ResearchPrincipal Investigator · Awarded by Veterans Administration Medical Center · 2011 - 2013

IPA - Sufeng Li

ResearchPrincipal Investigator · Awarded by Veterans Administration Medical Center · 2011 - 2012

Genetic Determinants of Susceptibility to Kidney Disease in African Americans

ResearchCo Investigator · Awarded by National Institutes of Health · 2009 - 2012

IPA - Sufeng Li

ResearchPrincipal Investigator · Awarded by Veterans Administration Medical Center · 2009 - 2011

Quit-smoking program for lung cancer patients' families

ResearchCo Investigator · Awarded by National Institutes of Health · 2003 - 2010

IPA Enyu Ding

ResearchPrincipal Investigator · Awarded by Veterans Administration Medical Center · 2007 - 2009

IPA - Sufeng Li

ResearchPrincipal Investigator · Awarded by Veterans Administration Medical Center · 2007 - 2009

Biomarker Studies for Novel Anti-Cancer Agents

ResearchConsultant · Awarded by National Institutes of Health · 2003 - 2008

Phase I/II Trial of ZD1839 and Celecoxib in Ex-Smokers

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2002 - 2007

Mentored Clinical Research Scholar Program

ResearchCo-Mentor · Awarded by National Institutes of Health · 2002 - 2006

Measurement of Hypoxia in Non-Small Cell Lung Carcinoma

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2002 - 2006

Genetic Analysis of Hereditary Macrothrombocytopenias

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2001 - 2004

External Relationships


  • Bristol Myers Squibb
  • Mirati
  • Plexus Communications
  • Prime Education
  • Regeneron Pharmaceuticals

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.